About me

Brunangelo Falini, M.D., is Professor of Hematology at the University of Perugia, Perugia, Italy. He received an M.D. degree and completed his residency in Internal Medicine at the University of Perugia. Then, he trained (1980-1981) with Robert J. Lukes on the immunological classification of human lymphomas at USC, Los Angeles, and worked (1982-1984) with David Y. Mason on the generation of monoclonal antibodies against lymphoma- and leukemia-associated antigens at Oxford University. During his scientific carrier, he has made important contributions in the field of lymphomas and leukemias by generating novel monoclonal antibodies directed against proteins encoded by genes involved in chromosomal translocations, by contributing to developing the modern classifications of lympho-hemopoietic neoplasms (REAL and WHO), and by applying in 1992 the first anti-CD30 immunotoxin for the therapy of refractory/relapsed Hodgkin lymphoma.